Skip to main content
ARS Home » Office of Technology Transfer » Development of Innovative Transmissible Spongiform Encephalopathy Vaccines

Development of Innovative Transmissible Spongiform Encephalopathy Vaccines
headline bar

Objective:  The USDA-Animal and Plant Health Inspection Service's (APHIS) National Wildlife Research Center is currently looking for an industrial partner to help develop and commercialize innovative transmissible spongiform encephalopathy (TSE) vaccines.    


Overview:  TSE is a neurological disease that causes chronic wasting disease in moose, deer and elk and the so called "Mad Cow Disease" in bovines.  There is a need to improve the overall performance of TSE therapies by studying new vaccine approaches.  Researchers at the USDA-APHISNationalWildlifeResearchCenter are developing these new vaccine approaches for TSE treatment.


Industry Type:  The ideal partner will have expertise in vaccine development and manufacture, and the ability to contribute both intellectually and financially to the project.


Where:  USDA-APHIS National Wildlife Research Center, 4101 LaPorte Avenue, Fort Collins, CO 80521.


Laboratory Mission:  The USDA-APHISNationalWildlifeResearchCenter is devoted to resolving problems caused by the interaction of wild animals and society. The Center applies scientific expertise to develop practical methods to resolve these problems and to maintain the quality of the environments shared with wildlife. 


If your company is interested in learning more about this opportunity, contact our regional Technology Transfer Coordinator:


Bryan Kaphammer, Ph.D.

USDA, ARS, NaturalResourcesResearchCenter

2150 Centre Avenue, Building D, Suite 300

Fort Collins, CO  80526-8119